Novan, Inc. today announced that preclinical data demonstrating the anti-viral effects of the Company’s nitric oxide-releasing drug candidates will be presented at the 31st International Papillomavirus Conference in Cape Town, South Africa. Thomas Broker, Ph.D., and Louise Chow, Ph.D., both of the University of Alabama at Birmingham, or UAB, are scheduled to present “Antiviral Efficacy of Nitric Oxide-Releasing Drug Candidates in Suppressing Productive Infection by HPV-18 in the Organotypic Epithelial Raft Culture Model System” on Thursday, Mar. 2. Drs.
Category: Western Cape, South Africa
‘Exceedingly ordinary’ Langley Rotarian becomes new international VP
Rohrs is currently serving as one of 17 Directors on the Rotary International Board, representing Canada, Bermuda, Alaska and 10 other states in the US northeast. With her husband Rhino , Rohrs is an owner and administrator at Rhide Technologies Inc., which supplies soil stabilization products for road construction.